NCT00846859

Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 162 (actual)
• Sponsor: Sahlgrenska University Hospital · Academic / Other
• Sex: All
• Age: 30 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The aim of the present clinical trial is to investigate whether 14 weeks of treatment with a prescription medication for smoking cessation (European trade name: Champix(R); US trade name: Chantix(R)), can reduce alcohol consumption in alcohol dependent individuals.

Conditions

• Alcohol Dependence

Interventions

Type	Name	Description
DRUG	varenicline (Champix/Chantix)	14 weeks of per oral tablet treatment in an escalating dosing regimen (0.5 mg - 1.0 mg/day; 1 - 2 tablets/day).
DRUG	placebo for varenicline	14 weeks of per oral tablet treatment in an escalating dosing regimen (1 - 2 tablets/day)

Timeline

• Start date: 2009-03-01
• Primary completion: 2010-08-01
• Completion: 2011-01-01
• First posted: 2009-02-19
• Last updated: 2011-07-21

Locations

3 sites across 1 country: Sweden